ADHD TREATMENT IN ADOLESCENTS: CASE REPORT ON THE INTEGRATION OF PHARMACOLOGICAL THERAPY AND PRECISION SPORTS

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity, often associated with academic, social, and occupational impairments. This study reports the case of a 15-year-old adolescent diagnosed with ADHD at age 9, whose therapeutic trajectory illustrates the challenges and benefits of transitioning from stimulant to non-stimulant medications. Initial treatment with immediate-release methylphenidate resulted in significant side effects, such as irritability and anxiety, leading to switching to extended-release methylphenidate, which brought partial improvements. At age 14, atomoxetine was introduced, resulting in more stable emotional control, reduced anxiety symptoms, and improved academic and sports performance.

The practice of archery, a precision sport, played a complementary role in the treatment, promoting focus, self-regulation, and motor control skills. The case demonstrates the efficacy of atomoxetine in the management of emotional comorbidities, such as anxiety, and highlights the importance of a multidisciplinary approach, integrating pharmacological therapy and structured extracurricular activities. In addition, it reinforces the need for continuous monitoring and therapeutic adjustments based on the individual needs of patients.

The results of this report contribute to the literature by demonstrating the clinical and psychosocial benefits of personalized interventions in the management of ADHD, especially in adolescents who face high cognitive and emotional demands. Future studies are recommended to explore the integration of different therapeutic approaches in ADHD, maximizing clinical and functional results.